SG55145A1 - Hematopoietic facilitatory cells and their uses - Google Patents
Hematopoietic facilitatory cells and their usesInfo
- Publication number
- SG55145A1 SG55145A1 SG1996007923A SG1996007923A SG55145A1 SG 55145 A1 SG55145 A1 SG 55145A1 SG 1996007923 A SG1996007923 A SG 1996007923A SG 1996007923 A SG1996007923 A SG 1996007923A SG 55145 A1 SG55145 A1 SG 55145A1
- Authority
- SG
- Singapore
- Prior art keywords
- bone marrow
- cells
- marrow cells
- hematopoietic
- engraftment
- Prior art date
Links
- 230000003394 haemopoietic effect Effects 0.000 title abstract 3
- 230000000494 facilitatory effect Effects 0.000 title abstract 2
- 210000002798 bone marrow cell Anatomy 0.000 abstract 4
- 210000004027 cell Anatomy 0.000 abstract 3
- 210000003958 hematopoietic stem cell Anatomy 0.000 abstract 2
- 210000000056 organ Anatomy 0.000 abstract 2
- 210000001519 tissue Anatomy 0.000 abstract 2
- 206010068051 Chimerism Diseases 0.000 abstract 1
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 230000005784 autoimmunity Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000010322 bone marrow transplantation Methods 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 230000007813 immunodeficiency Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 230000000998 lymphohematopoietic effect Effects 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46434—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91198992A | 1992-07-10 | 1992-07-10 | |
| US99654492A | 1992-12-24 | 1992-12-24 | |
| US6931593A | 1993-05-28 | 1993-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG55145A1 true SG55145A1 (en) | 1998-12-21 |
Family
ID=27371514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996007923A SG55145A1 (en) | 1992-07-10 | 1993-07-09 | Hematopoietic facilitatory cells and their uses |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0652943B1 (fr) |
| JP (1) | JP3917652B2 (fr) |
| AT (1) | ATE399854T1 (fr) |
| AU (1) | AU688734B2 (fr) |
| CA (1) | CA2139877C (fr) |
| DE (1) | DE69334227D1 (fr) |
| DK (1) | DK0652943T3 (fr) |
| ES (1) | ES2309985T3 (fr) |
| HK (1) | HK1010739A1 (fr) |
| NZ (2) | NZ255039A (fr) |
| PT (1) | PT652943E (fr) |
| SG (1) | SG55145A1 (fr) |
| WO (1) | WO1994001534A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE276277T1 (de) * | 1994-01-05 | 2004-10-15 | Univ Pittsburgh | Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden |
| WO1996015227A1 (fr) * | 1994-11-14 | 1996-05-23 | Novartis Ag | Methodes destinees a induire la mort cellulaire de cellules hematopoietiques primitives et compositions a cet effet |
| AU739277B2 (en) * | 1997-09-10 | 2001-10-11 | Emory University | Methods for inhibiting rejection of transplanted tissues by bone grafting |
| CN105168250B (zh) | 2004-10-25 | 2019-02-05 | 塞勒兰特治疗公司 | 增殖骨髓细胞群体的方法及其应用 |
| CN101421393B (zh) * | 2006-02-14 | 2013-08-14 | 塞勒兰特治疗公司 | 提高造血干细胞植入的方法和组合物 |
| US8632768B2 (en) * | 2008-05-30 | 2014-01-21 | University Of Louisville Research Foundation, Inc. | Human facilitating cells |
| JP6401445B2 (ja) * | 2013-10-10 | 2018-10-10 | 国立大学法人 東京大学 | 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| AU665042B2 (en) * | 1991-11-05 | 1995-12-14 | Board Of Trustees Of The Leland Stanford Junior University | Suppressor and progenitor cells |
-
1993
- 1993-07-09 PT PT93918173T patent/PT652943E/pt unknown
- 1993-07-09 SG SG1996007923A patent/SG55145A1/en unknown
- 1993-07-09 AU AU47717/93A patent/AU688734B2/en not_active Expired
- 1993-07-09 NZ NZ255039A patent/NZ255039A/en not_active IP Right Cessation
- 1993-07-09 WO PCT/US1993/006506 patent/WO1994001534A1/fr active Application Filing
- 1993-07-09 JP JP50354894A patent/JP3917652B2/ja not_active Expired - Lifetime
- 1993-07-09 EP EP93918173A patent/EP0652943B1/fr not_active Expired - Lifetime
- 1993-07-09 DK DK93918173T patent/DK0652943T3/da active
- 1993-07-09 ES ES93918173T patent/ES2309985T3/es not_active Expired - Lifetime
- 1993-07-09 CA CA002139877A patent/CA2139877C/fr not_active Expired - Lifetime
- 1993-07-09 DE DE69334227T patent/DE69334227D1/de not_active Expired - Lifetime
- 1993-07-09 AT AT93918173T patent/ATE399854T1/de active
-
1995
- 1995-01-24 NZ NZ299935A patent/NZ299935A/en unknown
-
1998
- 1998-10-29 HK HK98111586A patent/HK1010739A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08500009A (ja) | 1996-01-09 |
| DK0652943T3 (da) | 2008-11-03 |
| NZ255039A (en) | 1997-03-24 |
| AU4771793A (en) | 1994-01-31 |
| NZ299935A (en) | 2000-07-28 |
| HK1010739A1 (en) | 1999-06-25 |
| EP0652943A4 (fr) | 1996-02-07 |
| CA2139877C (fr) | 2006-09-19 |
| JP3917652B2 (ja) | 2007-05-23 |
| PT652943E (pt) | 2008-10-09 |
| AU688734B2 (en) | 1998-03-19 |
| ES2309985T3 (es) | 2008-12-16 |
| CA2139877A1 (fr) | 1994-01-20 |
| ATE399854T1 (de) | 2008-07-15 |
| WO1994001534A1 (fr) | 1994-01-20 |
| DE69334227D1 (de) | 2008-08-14 |
| EP0652943B1 (fr) | 2008-07-02 |
| EP0652943A1 (fr) | 1995-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luria et al. | Bone formation in organ cultures of bone marrow | |
| Lawler et al. | Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin | |
| SG147305A1 (en) | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis | |
| JP2003277293A5 (fr) | ||
| US7347999B2 (en) | Methods of treatment of hematopoietic disorders | |
| FR14C0051I1 (fr) | ||
| CA2121370A1 (fr) | Tolerance specifique a un greffon | |
| MD1444B2 (ro) | Metode de inducere a toleranţei celulelor T faţă de un transplant de organe sau ţesuturi | |
| WO2003012060A3 (fr) | Compositions cellulaires facilitant le greffage des cellules souches hematopoietiques et minimisant le risque de gvhd | |
| IL141877A0 (en) | Pharmaceutical compositions containing alpha4 integrin antagonists | |
| WO2002040049A3 (fr) | Blocage de la migration des lymphocytes t dans des tissus cibles epitheliaux gvh permettant d'obtenir des effets antitumoraux contre les malignites lympho-hematopoietiques sans gvh | |
| HK1052950B (zh) | 使用病毒淨化細胞 | |
| HUS1900041I1 (hu) | Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására | |
| HK1023599A1 (en) | Cells for preventing graft rejection in transplantation and their uses. | |
| CA2213322A1 (fr) | Thiols utilises pour favoriser la croissance de cellules hematopoietiques parentes | |
| SG55145A1 (en) | Hematopoietic facilitatory cells and their uses | |
| WO2002040640A3 (fr) | Procedes d'utilisation de cellules facilitatrices cd8+/tcr- dans le greffage de cellules souches hematopoietiques purifiees (csh) | |
| WO2002024244A3 (fr) | Procede de preparation et de traitement de tissus de greffe | |
| Turcotte et al. | Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis | |
| WO2003029432A3 (fr) | Cellule souche mesenchymateuse humaine | |
| Vigneau et al. | Stem cells and kidney injury | |
| Anwar et al. | Therapeutic potential of umbilical cord stem cells for liver regeneration | |
| MX9304187A (es) | Celulas facilitatorias hematopoyeticas. | |
| Stefani et al. | Laparoscopic versus surgical transfer of ovine embryos | |
| GB9710698D0 (en) | Composition |